GIM
BSX icon

Goelzer Investment Management’s Boston Scientific BSX Stock Holding History

Goelzer Investment Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$542K Buy
12,691
+36
+0.3% +$1.96K 0.02% 226
2026
Q1 		$794K Sell
12,655
-22,393
-64% -$1.79M 0.04% 183
2025
Q4 		$3.34M Sell
35,048
-264
-0.7% -$25.9K 0.16% 110
2025
Q3 		$3.45M Sell
35,312
-225
-0.6% -$23.3K 0.18% 109
2025
Q2 		$3.82M Sell
35,537
-616
-2% -$62.3K 0.21% 101
2025
Q1 		$3.65M Buy
36,153
+816
+2% +$82.2K 0.21% 102
2024
Q4 		$3.16M Buy
35,337
+628
+2% +$55.3K 0.18% 112
2024
Q3 		$2.91M Sell
34,709
-7,496
-18% -$591K 0.16% 117
2024
Q2 		$3.25M Buy
42,205
+615
+1% +$45K 0.18% 110
2024
Q1 		$2.85M Buy
41,590
+693
+2% +$44.6K 0.16% 115
2023
Q4 		$2.36M Buy
40,897
+981
+2% +$52.4K 0.15% 120
2023
Q3 		$2.11M Sell
39,916
-112
-0.3% -$5.87K 0.15% 115
2023
Q2 		$2.17M Sell
40,028
-782
-2% -$40.8K 0.18% 115
2023
Q1 		$2.04M Sell
40,810
-1,441
-3% -$67.9K 0.18% 122
2022
Q4 		$1.95M Sell
42,251
-1,426
-3% -$61.7K 0.17% 130
2022
Q3 		$1.69M Buy
43,677
+74
+0.2% +$2.97K 0.17% 129
2022
Q2 		$1.63M Sell
43,603
-2,156
-5% -$87.8K 0.16% 133
2022
Q1 		$2.03M Buy
45,759
+630
+1% +$27.3K 0.18% 132
2021
Q4 		$1.92M Sell
45,129
-1,035
-2% -$43.5K 0.16% 144
2021
Q3 		$2M Sell
46,164
-2,173
-4% -$96.1K 0.18% 141
2021
Q2 		$2.07M Sell
48,337
-2,574
-5% -$108K 0.17% 144
2021
Q1 		$1.97M Sell
50,911
-1,786
-3% -$67.6K 0.17% 142
2020
Q4 		$1.89M Sell
52,697
-1,158
-2% -$41.7K 0.17% 138
2020
Q3 		$2.06M Sell
53,855
-2,949
-5% -$114K 0.19% 133
2020
Q2 		$1.99M Sell
56,804
-3,173
-5% -$114K 0.19% 132
2020
Q1 		$1.96M Sell
59,977
-2,269
-4% -$88.6K 0.22% 116
2019
Q4 		$2.81M Sell
62,246
-2,192
-3% -$91.7K 0.24% 115
2019
Q3 		$2.62M Sell
64,438
-709
-1% -$30K 0.24% 117
2019
Q2 		$2.8M Sell
65,147
-304
-0.5% -$11.7K 0.26% 111
2019
Q1 		$2.51M Buy
65,451
+1,149
+2% +$43.9K 0.24% 127
2018
Q4 		$2.27M Sell
64,302
-21,893
-25% -$794K 0.29% 115
2018
Q3 		$3.32M Sell
86,195
-2,446
-3% -$85.4K 0.37% 97
2018
Q2 		$2.9M Sell
88,641
-4,600
-5% -$139K 0.34% 106
2018
Q1 		$2.55M Buy
93,241
+18,745
+25% +$509K 0.31% 117
2017
Q4 		$1.85M Sell
74,496
-525
-0.7% -$14.5K 0.21% 136
2017
Q3 		$2.19M Sell
75,021
-1,335
-2% -$36.9K 0.26% 125
2017
Q2 		$2.12M Buy
+76,356
New +$2.03M 0.26% 121

Other funds holding BSX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return
BPCE
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return

Goelzer Investment Management's BSX Position: Q2 2026 in Review

Goelzer Investment Management increased its Boston Scientific (BSX) stake by 0.28% in Q2 2026, buying an estimated $1.96K and bringing the position to 12,691 shares worth $542K. The position accounts for 0.02% of the portfolio, ranked #226.

Goelzer Investment Management first reported a position in BSX in Q2 2017 and has held it in 37 quarters since. The position peaked at $3.82M in Q2 2025. 338 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Goelzer Investment Management held 12,691 shares of Boston Scientific worth $542K as of Q2 2026.
  • Goelzer Investment Management bought 36 Boston Scientific shares in Q2 2026, an estimated $1.96K.
  • Boston Scientific made up 0.02% of Goelzer Investment Management's portfolio in Q2 2026, its #226 holding.
  • Goelzer Investment Management first reported a position in Boston Scientific in Q2 2017 and has held it in 37 quarters since.
  • Goelzer Investment Management's Boston Scientific position peaked at $3.82M in Q2 2025.
  • 338 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Goelzer Investment Management's 13F filing for Q2 2026, filed 15 Jul 2026.